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Objective: Type 2 diabetes (T2D) is a complex disease characterized by pancreatic islet dysfunction, insulin resistance, and disruption of blood
glucose levels. Genome-wide association studies (GWAS) have identiﬁed > 400 independent signals that encode genetic predisposition. More
than 90% of associated single-nucleotide polymorphisms (SNPs) localize to non-coding regions and are enriched in chromatin-deﬁned islet
enhancer elements, indicating a strong transcriptional regulatory component to disease susceptibility. Pancreatic islets are a mixture of cell types
that express distinct hormonal programs, so each cell type may contribute differentially to the underlying regulatory processes that modulate T2D-
associated transcriptional circuits. Existing chromatin proﬁling methods such as ATAC-seq and DNase-seq, applied to islets in bulk, produce
aggregate proﬁles that mask important cellular and regulatory heterogeneity.
Methods: We present genome-wide single-cell chromatin accessibility proﬁles in >1,600 cells derived from a human pancreatic islet sample
using single-cell combinatorial indexing ATAC-seq (sci-ATAC-seq). We also developed a deep learning model based on U-Net architecture to
accurately predict open chromatin peak calls in rare cell populations.
Results: We show that sci-ATAC-seq proﬁles allow us to deconvolve alpha, beta, and delta cell populations and identify cell-type-speciﬁc
regulatory signatures underlying T2D. Particularly, T2D GWAS SNPs are signiﬁcantly enriched in beta cell-speciﬁc and across cell-type
shared islet open chromatin, but not in alpha or delta cell-speciﬁc open chromatin. We also demonstrate, using less abundant delta cells,
that deep learning models can improve signal recovery and feature reconstruction of rarer cell populations. Finally, we use co-accessibility
measures to nominate the cell-speciﬁc target genes at 104 non-coding T2D GWAS signals.
Conclusions: Collectively, we identify the islet cell type of action across genetic signals of T2D predisposition and provide higher-resolution
mechanistic insights into genetically encoded risk pathways.
Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Original Articleinteraction is known to be associated with type-2-diabetes (T2D)
pathophysiology [2]. However, the exact cellular mechanisms through
which different risk factors contribute to disease risk are not
completely understood. Using GWAS and eQTL mapping approaches,
recent studies have discovered >400 independent signals (>240 loci)
associated with T2D and T2D-associated traits [3], although remark-
ably, more than 90% localize to non-protein-coding regions of the
genome [4]. Growing evidence suggests that many of these variants
likely inﬂuence the RNA expression and cellular function of human
pancreatic islets by altering transcription factor binding, critical com-
ponents of a cellular regulatory network [5e9].
High-throughput epigenomic proﬁling methods such as ATAC-seq [10]
and DNase-seq [11] have enabled proﬁling of chromatin accessibility
across samples in a tissue-wide manner, providing the opportunity to
identify millions of context-speciﬁc regulatory elements. However,
these bulk measurements of chromatin accessibility limit the precise
understanding of how tissue heterogeneity and multiple cell types in
the population contribute to overall disease etiology [12]. Recent ad-
vances in single-cell transcriptomic and epigenomic proﬁling methods
have enabled an unbiased identiﬁcation of cell-type populations and
regulatory elements in a heterogeneous biological sample. By mapping
the chromatin-regulatory landscape at a single-cell resolution, recent
single-nuclei studies have demonstrated the potential to discover
complex cell populations, link regulatory elements to their target
genes, and map regulatory dynamics during complex cellular differ-
entiation processes [13e16]. The pancreatic islet gene expression
landscape has been investigated at single-cell resolution in existing
studies [17,18], but chromatin accessibility studies have been limited
to ﬂuorescence-activated cell sorting (FACS) methods to obtain cell-
type populations [19,20]. FACS-based methods will miss identiﬁca-
tion of unknown or rarer cell-populations and are unable to produce
pure cell-type populations due to reliance on the speciﬁcity of cell
surface markers [21,22].
In this study, we present a genome-wide map of chromatin accessi-
bility in >1,600 nuclei derived from a human pancreatic islet sample
using single-cell combinatorial indexing ATAC-seq (sci-ATAC-seq)
[23]. Sci-ATAC-seq enables us to deconvolve cell populations and
identify cell-type-speciﬁc regulatory signatures underlying T2D.
Notably, T2D GWAS SNPs are signiﬁcantly enriched in beta cell-
speciﬁc and across cell-type shared islet open chromatin, but not in
alpha or delta cell-speciﬁc open chromatin. We then develop a novel
deep learning-based strategy using concepts borrowed from image
upscaling methods to improve signal recovery and feature recon-
struction for low abundance cell populations and apply it successfully
to delta cells (<5% of the total islet population) identiﬁed in our study.
We anticipate that our deep learning method will enable analysis of
heterogeneous tissues that may be harder to obtain in large numbers
or contain rare subpopulations. We validate our ﬁndings against
multiple independent and orthogonal datasets that consistently support
the high quality and reproducibility of our results. Collectively, these
results identify the islet cell type of action across genetic signals of T2D
predisposition and provide higher-resolution mechanistic insights into
genetically encoded pathophysiology.
2. MATERIALS AND METHODS
2.1. Bulk islet ATAC-seq
2.1.1. Sample processing
Human pancreatic islet samples were procured and processed as
described by Varshney et al. [8]. Brieﬂy, the islets were obtained from110 MOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier G
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according to the NHGRI institutional review board-approved protocols.
The islets were shipped overnight from the distribution center. Upon
receipt, we pre-warmed the islets to 37 in shipping media for 1e2 h
before harvest. A total of w50e100 islet equivalents (IEQs) were
harvested and transposed in triplicate following the methods of
Buenrostro et al. [10]. The ATAC-seq library was barcoded and
sequenced 2  125 bp on a HiSeq 2000.
2.1.2. ATAC-seq analysis
Sequencing adapters were trimmed using CTA (v0.1.2) [24] and
aligned to the hg19 reference genome using BWA-MEM (v0.7.15,
r1140, options: -I 200, 200, 5000) [25]. Picard MarkDuplicates
(v2.18.27) was used for duplicate removal and Samtools [26] was
used to ﬁlter for autosomal, properly paired, and mapped read pairs
with mapping quality 30 (v1.9, options: -f3 -F3340 -q30). Replicates
across each sample were merged into a single ﬁle using Samtools
merge. For peak calling, each sample was downsampled to 25 million
(M) reads and converted to a BED ﬁle. We then used MACS2 [27] to call
broad peaks (v2.1.1.20160309; options: –nomodel –broad –shift -100
–extsize 200 –keep-dup all –SPMR) and removed those with
FDR> 0.05 and overlapping with ENCODE hg19 blacklists [28]. ATAC-
seq coverage tracks were displayed using the UCSC Genome Browser
and Integrative Genomics Viewer (IGV). Summary statistics were
calculated using ataqv (v1.0) [29] and are available in interactive and
downloadable formats online (Table S7). For comparative purposes,
we performed the same read trimming, alignment, ﬁltering, down-
sampling, and peak calling steps on publicly available ATAC-seq data
(Table S1). Peaks from each sample were merged to create a master
peak set and Spearman’s correlation was computed on the RPKM-
normalized read-count matrix.
2.1.3. Determination of high-conﬁdence peaks
We randomly sampled 2.5 M reads from each sample using Samtools
view and pooled them into one ﬁle so that each sample was equally
represented. Peaks were called on the pooled ﬁle as discussed in the
previous paragraph. We then determined the number of samples
overlapping with each master peak using peaks called on individual
samples.
2.1.4. Overlap of reads with ChromHMM states
We tested for enrichment of the ATAC-seq peaks across 13 islet-
speciﬁc chromatin states using Genomic Association Tester (GAT)
[30]. We ran GAT (v1.3.5, options: –number-samples 10,000) and
ﬁltered the chromatin states with no signiﬁcant enrichment (Bonferroni
adjusted p-value < 0.05) of their peaks. Fold enrichment (log2) values
across the chromatin states were clustered using hierarchical clus-
tering of the correlation matrix.
2.2. Sci-ATAC-seq analysis
2.2.1. Sample processing
We used the combinatorial cellular indexing method to generate
single-nuclei chromatin accessibility data as previously described by
Cusanovich et al. [23]. Brieﬂy, a suspension of islet cells was obtained
and pelleted for 5 min at 4 C 500g. The medium was aspirated and
the cells were washed once in 1 ml PBS. The cells were pelleted again
for 5 min at 4 C 500g and then resuspended in 1 ml of cold lysis
buffer (10 mM TriseHCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, and 0.1%
IGEPAL CA-630 supplemented with 1 protease inhibitors (Sigma
P8340)). Nuclei were maintained on ice whenever possible after thismbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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point. Then 10 ml of 300 mM DAPI stain was added to 1 ml of lysed
nuclei for sorting. To prepare for sorting, 19 ml of freezing buffer
(50 mM Tris at pH 8.0, 25% glycerol, 5 mM MgOAc2, 0.1 mM EDTA
supplemented with 5 mM DTT, and 1 protease inhibitors (Sigma
P8340)) was aliquoted into each well of a 96-well LoBind plate. A total
of 2,500 DAPIþ nuclei (single-cell sensitivity) were sorted into each
well of the plate containing freezing buffer. The plate was sealed with a
foil plate sealer and then snap frozen in liquid nitrogen. The frozen
plate was then transferred directly to a 80 C freezer. The sample
was subsequently shipped from NIH to UW overnight on dry ice. The
plate was then thawed on ice and supplemented with 19 ml of Illumina
TD buffer and 1 ml of custom-indexed Tn5 (each well received a
different Tn5 barcode). The nuclei were tagmented by incubating at
55 C for 30 min. The reaction was then quenched in 20 mM EDTA and
1 mM spermidine for 15 min at 37 C. The nuclei were then pooled and
stained with DAPI again. A total of 25 DAPIþ nuclei were then sorted
into each well of a 96-well LoBind plate containing 11.5 ml of Qiagen
EB buffer, 800 of mg/ml BSA, and 0.04% SDS. Then 2.5 ml of 10 mM P7
primers were added to each sample and the plate was incubated at
55 C for 15 min. Then 7.5 ml of NPM was added to each well. Finally,
2.5 ml of 10 mM P5 primers were added to each well and the samples
were PCR ampliﬁed at following cycles: 72 C for 3 min, 98 C for 30 s,
then 20 cycles of 98 C for 10 s, 63 C for 30 s, and 72 C for 1 min.
The exact number of cycles was determined by ﬁrst doing a test run on
8 samples on a real-time cycler with SYBR Green (0.5  ﬁnal con-
centration). The PCR products were then pooled and cleaned on Zymo
Clean & Concentrator 5 columns (the plate was split across 4 col-
umns), eluted in 25 ml of Qiagen EB buffer, and then all 4 fractions
were combined and cleaned using a 1 AMpure bead cleanup before
eluting in 25 ml of Qiagen EB buffer again. The molar concentration of
the library was then quantiﬁed on a Bioanalyzer 7500 chip (including
only fragments in the 200e1000 bp range) and sequenced on an
Illumina NextSeq at 1.5 pM concentration.
2.2.2. QC and pre-processing
Step 1. Barcode correction and ﬁltering. Each barcode consisted of four
8-bp-long indexes (i5, i7, p5, and p7). Reads with barcode combi-
nations containing more than 3 edit distances for any index were
removed. If a barcode was within 3 edits of an expected barcode and
the next best matching barcode was at least 2 edits further away, we
corrected the barcode to its best match. Otherwise, the barcode was
classiﬁed as ambiguous or unknown.
Step 2. Adapter trimming and alignment. Adapters were removed
using Trimmomatic [31] with NexteraPE adapters as input (ILLUMI-
NACLIP:NexteraPE.fa:2:30:10:1:true TRAILING:3 SLI-
DINGWINDOW:4:10 MINLEN:20) and aligned to an hg19 reference
using BWA-MEM (v0.7.15, r1140, options: -I 200, 200, 5000) [25]. The
ﬁnal alignment was ﬁltered using Samtools to remove unmapped
reads and reads mapping with quality <10 (-f3 -F3340 -q10) as well
as reads that were associated with ambiguous or unknown barcodes.
Step 3. Deduplication and nuclei detection. Duplicates from the pruned
ﬁle were removed using a custom Python script on a per-nucleus
basis. Using the distribution of reads per barcode, we applied bi-
clustering as implemented in the mclust [32] R package to differentiate
between the background barcodes and barcodes that corresponded to
a nucleus. Using a list of non-background barcodes, we split the
aggregate BAM ﬁle into constituent BAM ﬁles corresponding to each
barcode representing a single nucleus using a custom Python script.
Step 4. Quality assessment of each single nucleus. For each single
nucleus, we computed ATAC-seq quality metrics such as the fragment
length distribution, transcription start site (TSS) enrichment, short-to-MOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier GmbH. This is an open access artic
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reads overlapping peaks. We removed nuclei with a) total reads
outside the 5%e95% range (34578e226755) of all of the nuclei and
b) TSS enrichment of<2.7 (5% tile) from further downstream analysis.
Step 5. Aggregate sci-ATAC-seq peaks. We pooled reads from the
ﬁltered barcodes from the previous steps to create an aggregate BAM
ﬁle. Peaks were called and ﬁltered as described previously in the Bulk
islet ATAC-seq analysis section.
2.3. Cluster analysis
2.3.1. Feature selection and clustering
We generated a list of TSS distal peaks (>5 kb away from the nearest
TSS based on RefSeq genes [33]) from the aggregate sci-ATAC-seq
data. For each nucleus, we counted the number of reads over-
lapping the peaks using the Rsubread package [34]. We then adopted
a logistic regression approach to remove peaks in which the binarized
accessibility across nuclei was signiﬁcantly associated (Bonferroni
corrected p-value < 0.05) with the sequencing depth. This approach
should help reduce the bias associated with the sequencing depth, as
the remaining peaks are no longer associated with this technical
factor, a strategy that has been successfully implemented in single-cell
RNA-seq data analysis [35]. The resulting count matrix was RPKM-
normalized and reweighted using the term-frequency and inverse
document frequency (TF-IDF) method [13]. To accomplish this, we ﬁrst
weighted all the sites for individual nuclei by the total number of sites
accessible in that cell (“term frequency”). We then multiplied these
weighted values by log (1 þ the inverse frequency of each site across
all cells), the “inverse document frequency.” The TF-IDF transformed
matrix was then reduced to 30 principal components using principal
component analysis (PCA) and used as input to generate two-
dimensional embedding using the uniform manifold approximation
method (UMAP, n_neighbors ¼ 20) [36]. We identiﬁed clusters in the
two-dimensional embedding in an unsupervised manner using a
density-based clustering method (HDBSCAN, minPts ¼ 20) as
implemented in the DBSCAN R package [37].
2.3.2. Cell identity assignment and validation
The cell identities were assigned based on de facto cell-type-speciﬁc
hormone markers: INS-IGF2 (beta), GCG (alpha), and SST (delta)
among others. A marker gene was considered to be present in a nuclei
if a read mapped within 5 kb of the GENCODE (v19) gene body
annotation [38]. For additional veriﬁcation of the cell identity, we
computed the RPKM-normalized aggregate ATAC-seq signal across
cell-type marker genes reported in two independent islet scRNA-seq
studies [17,39]. Finally, we evaluated the enrichment of the cells
from each cell-type cluster relative to their expected population pro-
portion using a two-sided binomial test across 10 bins of sequencing
depth (w145 cells/bin).
2.4. Deep learning signal and peak upscaling
2.4.1. Model design, training, and validation strategy
The U-Net model [40] takes input sequences and outputs prediction
sequences. The goal of model training is to reduce the error between
the prediction output and a representation of the ground truth. For
signal upscaling, the input sequence was base-wise scores of BAM
pileups (read-depth) corresponding to a subsample of n cells
(randomly sampled from 600 cells) and the output sequence was
base-wise scores of BAM pileups using reads from all 600 cells. Peak
upscaling not only uses the subsampled BAM pileup scores as inputsle under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 111
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MACS2 on the subsampled BAM alignments. The output sequences for
peak upscaling are the binary base-wise values from calling peaks
with MACS2 on the data. We created two models, each separately
based on the data from the alpha and beta cells. Because both had
different numbers of constituent single nuclei, we matched the size of
the output dataset by randomly sampling 600 cells from each cell-type
cluster. The input datasets were created by sampling n cells from the
set of 600 cells such that the total number of reads was similar across
both models. We did not set any explicit constraints on the number of
peaks to be called by this approach.
The network architecture of the U-Net model used in this study is
illustrated in Fig. S2A. It consisted of a contracting convolutional path
(left side) and an expansive deconvolutional path (right side). The
contracting path consisted of repeated applications of two kernel
size 11 convolutions (unpadded convolutions) with rectiﬁed linear
unit (ReLU) activation and a kernel size 2 max pooling operation with
stride 2 for downsampling. Each downsampling step halves the
length of the activation sequence while doubling the number of
feature channels. Every step in the expansive path consists of a
kernel size 2 deconvolution layer with a linear activation function that
halves the number of feature channels, a concatenation with the
correspondingly cropped feature map from the contracting path, and
two kernel size 11 convolution layers with ReLU activations. The
cropping is necessary due to the loss of border sequence steps in a
non-padded convolution. At the ﬁnal layer, a kernel size 1 convo-
lution with either an ReLU (for signal upscaling) or sigmoid (for peak
upscaling) activation function generates the sequence of predictions.
Due to the use of unpadded convolutions, the prediction sequence is
shorter than the input sequence by a constant border width.
Although the U-Net model can accept arbitrary length input se-
quences, we ﬁxed all of the training samples to have a length of
6700, which resulted in output prediction sequences with a length of
4820. In total, the network had ﬁve steps each in the contracting and
expansive paths for a total of 27 convolutional layers and 8,998,529
training parameters. The model was implemented using Keras [41]
with the TensorFlow [42] backend, and the experiments were run
using Titan Xp and GTX 1080 Ti GPUs.
To reduce overﬁtting, we split chromosomes into training, validation,
and testing sets. The model was ﬁt using the ADAM optimizer [43]
with a learning rate of 1e-5 and a batch size of 128 for 50 epochs.
Separate loss functions, and hence models, were used to solve signal
and peak upscaling. For signal upscaling, we used the mean squared
error base-wise loss function. For peak upscaling, the loss function
was the sum of the cross-entropy base-wise loss and the Dice co-
efﬁcient loss, also known as the F1 score. We used the mean
average precision, a common evaluator for object detection, and
Pearson’s correlation as the output evaluation metrics for the peak
and signal upscaling, respectively. The downscaling and model
training were repeated for n ¼ 5, 10, 28, 50, 100, 200, 300, 400,
and 500 cells.
2.4.2. Generating upscaled peaks
To select a subset of high-conﬁdence peaks from the predicted model
output, we adopted a post-hoc approach in which we compared the
number of cell-type-speciﬁc peaks for alpha, beta, and delta cells, and
chose a threshold in which they had a similar number. For the pre-
dicted delta cell peaks, we combined the results from the alpha and
beta models at the same threshold using bedtools [44] intersect
(v.2.27.1) after ﬁltering for the chosen threshold.112 MOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier G
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2.5.1. Cell-type-speciﬁc peaks
Peaks speciﬁc to each cell type were obtained by comparing the peaks
in one cell-type with all of the other cell types using bedtools.
2.5.2. T2D GWAS SNPs enrichment
Enrichment of T2D-associated GWAS SNPs from DIAMANTE [3] was
tested using GREGOR (v1.3.1) [45]. Speciﬁcally, we used the following
parameters: r2 threshold (for inclusion of SNPs in LD with the diabetes-
associated GWAS SNPs) ¼ 0.80, LD window size ¼ 1 Mb, and min-
imum neighbor number ¼ 500. The p-values were adjusted according
to the Bonferroni threshold for multiple testing burdens.
2.5.3. Conditional fGWAS enrichment analysis
We used fGWAS [46] to model the shared properties of loci affecting a
trait. We ran fGWAS (v0.3.6) with DIAMANTE T2D GWAS summary data
and cell-type ATAC-seq peaks from three cell types as input annota-
tions. For each individual annotation, the output model provided
maximum likelihood enrichment parameters and annotations were
considered signiﬁcantly enriched if the parameter estimates and 95%
conﬁdence interval (CI) did not overlap zero. We then used fGWAS to
run a conditional analysis in a pair-wise manner in which the
enrichment of one model was conditionally evaluated on the output
models from the other annotations.
2.5.4. Validating cell-type peaks using scRNA-seq signature genes
We evaluated the enrichment of scRNA-seq derived signature genes
(scRSGs) in 28-cell MACS2 and upscaled peak calls using GAT [30].
We ran GAT (v1.3.5, options: –number-samples 10,000) with the union
of all peaks as workspaces and scRSGs as segments.
2.5.5. Transcription factor motif enrichment
We used motif PWN scans from [47]. Brieﬂy, we used biallelic SNPs
and short indels from the 1,000 Genomes Project (release v5) [48] to
generate comprehensive scans with FIMO [49] using the background
nucleotide frequencies from hg19 and a p-value < 1e-4. We only kept
motif instances that intersected mappable regions and did not intersect
blacklisted regions. We then tested for the enrichment of motifs across
cell-type-speciﬁc peaks using GAT (v1.3.5, options: –number-samples
100,000) [30]. We used a union of the top 100 motifs (by log fold
enrichment) for each annotation and clustered them using hierarchical
clustering.
2.6. Linking SNPs to target genes
2.6.1. Cicero co-accessibility analysis
To link TSS distal ATAC-seq peaks with target genes, we used Cicero
[50], which identiﬁes co-accessible pairs of DNA elements using
single-cell chromatin accessibility data. We used these results to infer
connections between regulatory elements and their target genes. We
ran Cicero (v1.0.15, default parameters) with cells from the alpha and
beta cell clusters separately. To accomplish this, we ﬁrst called peaks
on each cluster and counted the number of reads per nuclei over-
lapping the peaks. The resulting count matrix was used as input to
Cicero along with the UMAP projection for each cluster. Finally, to
decide a threshold for ﬁltering co-accessible peak pairs, we computed
the Fisher odds ratio for the enrichment of co-accessible peaks vs
distance-matched non-co-accessible peaks (co-accessibility< 0) with
three different three-dimensional chromatin looping data sets: islet Hi-mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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C [51], islet promoter capture Hi-C (pcHi-C) [52], and EndoC Pol2 ChIA-
PET anchors [53]. For overlap, we checked whether both the ends of
the Cicero loops intersected with both of the anchors from the
experimental chromatin looping data. Public epigenome browser
session links are included in Table S7.2.6.2. T2D GWAS SNP overlap analysis
To link T2D GWAS SNPs with target genes, we utilized 380 indepen-
dent GWAS signals from DIAMANTE that were genetically ﬁne-mapped
to 99% credible sets using a Bayesian approach. In this framework,
each SNP has a posterior probability for being causal for the associ-
ation in that region. These posterior probabilities are the ratio of evi-
dence for each variant vs all of the others, which makes it easy to
directly compare the variants. A genetic credible set is then deﬁned as
the minimum set of SNPs that contains all SNPs with a probability
greater than or equal to 0.01. We ﬁltered the SNPs within each set to
have >0.05 posterior probability of association (PPAg). We then
checked for each GWAS signal whether SNPs passing the criteria
mapped within 1 kb of cell-type-speciﬁc ATAC-seq peaks. To obtain
Cicero target genes, we checked if an ATAC-seq peak was a) within
1 kb of a variant, b) outside the 1 kb range of a RefSeq TSS, and (c)
linked to ATAC-seq peaks within 1 kb of a RefSeq TSS. The binary
overlap matrix was clustered using hierarchical clustering with the
binary distance method. Tables containing the number of SNPs within
each credible set and speciﬁc variants overlapping cell-type-speciﬁc
ATAC-seq peaks are available in Table S8 and Table S9.Figure 1: Schematic of sci-ATAC-seq study. (A) Sci-ATAC-seq protocol for generating
identify constituent cell types and use a deep learning model to predict peaks on the cluste
sci-ATAC-seq islet sample. Bottom tracks show the signal across a random subset of up to
0 and 2. (C) Spearman’s correlation between aggregate sci-ATAC-seq, 13 bulk islets, 3 adip
of aggregate sci-ATAC-seq TSS proximal and distal peaks across bulk islet derived Chrom
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3.1. Sci-ATAC-seq captures tissue relevant characteristics similar
to bulk ATAC-seq
Pancreatic islets represent approximately 1e2% (by mass) of total
pancreatic tissue [1] and therefore require specialized approaches to
isolate in a manner that maintains viability. We obtained a highly pure
(>95% purity and >92% viability) sample of human pancreatic islet
tissue from one individual (cadaveric donor, female, 43 years old, and
non-diabetic) and proﬁled chromatin-accessibility using the sci-ATAC-
seq protocol [23] as described previously (Figure 1A, Table S2). In total,
we obtained 1,690 single-cell ATAC-seq datasets with depths ranging
from 17,667 to 415,237 (median: 79,482) reads per nucleus and TSS
enrichment from 0.77 to 9.80 (median: 3.91) after removing the
background barcodes (Fig. S1A). For quality assessment of each single
nucleus, we reasoned that the total reads and TSS enrichment values
are more suitable metrics for identifying nuclei with poor signal-to-
noise ratio than using fraction of reads in peaks as the latter may
bias counts for under-represented cell-type populations in the analysis
(Figs. S1BeC). Based on these criteria, we obtained high-quality sci-
ATAC-seq data for 1,456 single nuclei. In addition to the sci-ATAC-seq
data, we generated high-quality bulk ATAC-seq data for 10 islet
samples with >47 M reads and >4.4 TSS enrichment per sample
(Table S3). Using our approach to identify high-conﬁdence (master)
peak calls across the samples (see Methods), we obtained 106,460
bulk islet accessible chromatin peaks.single-nuclei ATAC-seq data from a pancreatic islet sample. The data are then used to
rs with fewer nuclei count. (B) ATAC-seq signal tracks for 10 bulk islet samples and the
400 single nuclei. Signal tracks are normalized to one million reads and scaled between
ose, 2 muscle, 2 CD4þ T-cells, and 1 GM12878 sample (see Table S1). (D) Distribution
HMM segmentations.
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Original ArticleWe then compared the aggregate islet sci-ATAC-seq data with bulk
ATAC-seq samples from islets and other tissues. To accomplish this,
we called 156,311 peaks on the aggregate sci-ATAC-seq. We found
that the aggregate sci-ATAC-seq proﬁles were concordant and clus-
tered together with the other bulk islet samples, indicating that
aggregate sci-ATAC-seq can capture chromatin accessibility in a
manner equivalent to bulk ATAC-seq assays (Figure 1BeC, Figure
S1DeE). Further, to understand whether the aggregate sci-ATAC-
seq peaks captured islet-speciﬁc regulatory features, we compared
the distribution of peaks across ChromHMM chromatin state maps
across eight different tissues, including islets and the EndoC human
beta cell line [8]. We found that the islet sci-ATAC-seq peaks over-
lapped active TSS and active enhancer segmentations in the islet and
EndoC (a beta cell line) chromatin state maps to a larger extent
compared to other tissues (Figure 1D). Because ChromHMM enhancerFigure 2: Clustering and identiﬁcation of cell-type clusters in sci-ATAC-seq data. (A)
point into four clusters as identiﬁed by density-based clustering. (B) Enrichment of cells f
sequencing depth bins. Sequencing depth increases with the bin number. (C) Genome bro
IGF2), delta (SST), and a housekeeping gene (GAPDH). Tracks are normalized to one million
scheme utilizing cell-type signature genes as identiﬁed by an islet scRNA-seq study by Law
cell-type signature genes for alpha, beta, and delta cells. Number of signature genes for
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with tissue-speciﬁc enhancer activity [5,54], our results indicate that
the sci-ATAC-seq data captured the underlying islet-speciﬁc chromatin
architecture similar to bulk islet ATAC-seq assays. Overall, these re-
sults indicate that our aggregate islet sci-ATAC-seq data are of high
quality and suggests that the individual nuclei could reveal cell-speciﬁc
patterns of the constituent cell types.
3.2. Sci-ATAC-seq reveals constituent cell types in pancreatic
islets
The aggregate sci-ATAC-seq proﬁle of the islet is constituted of signals
from distinct cell types. To identify these cell types, we leveraged the
observation that TSS distal regions capture cell-type-speciﬁc acces-
sibility patterns and are effective at classifying constituent cell types
[55]. We adopted a multi-step process to robustly detect and identifyUMAP projection with clustering of 1,456 single-nuclei islets represented by each single
rom each cluster relative to their expected population proportion across different read
wser tracks showing signals at different cell-type marker loci: alpha (GCG), beta (INS-
reads and scaled between 0 and 5. (D) Overview of the independent cluster veriﬁcation
lor et al. (2017). (E) Plot of aggregate ATAC-seq signals (RPKM) at scRNA-seq derived
each cell type indicated in the title.
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islet subpopulations (see Methods, Table S4). This approach produced
four distinct clusters (Figure 2A). To assign a cell-type identity to the
clusters, we merged the nuclei in each cluster to create aggregate
chromatin accessibility proﬁles and systematically examined the pat-
terns of accessibility at multiple cell-type marker loci. We found three
clusters that had distinct chromatin-accessibility patterns at GCG, INS-
IGF2, and SST loci corresponding to three major islet cell types: alpha,
beta, and delta cells (Figure 2B). The fourth cluster (95 nuclei,w7% of
all nuclei) showed a “mixed” cell-type appearance as shown by signals
at multiple cell-speciﬁc markers. We reasoned that these were likely to
be nuclei doublets resulting from barcode collisions inherent to the
combinatorial indexing protocol and thus should have skewed ATAC-
seq read coverage. Indeed, we observed that the nuclei assigned to
the mixed cell cluster were signiﬁcantly (nominal p-value ¼ 7.3e-7,
binomial test) enriched in the high sequencing depth bin relative to the
nuclei from other clusters (Figure 2C). As such, these nuclei were
removed from further analyses, yielding a total of 1,361 nuclei with
51%, 47%, and 2% identiﬁed as beta, alpha, and delta, respectively.
These estimates agree with the existing estimates of pancreatic islet
cell-type proportions observed via confocal microscopy or single-cell
transcriptomics experiments [17,39,56,57]. We additionally validated
the identity of our clusters using ﬁndings from two independent islet
scRNA-seq studies [17,39]. For both studies, we observed that our
chromatin accessibility proﬁles across cell-type signature genes were
enriched with our assigned cluster identities (Figure 2E, Fig. S1F).
We then analyzed the chromatin accessibility proﬁle for each cell-type
cluster. To accomplish this, we aggregated the nuclei within each
cluster and identiﬁed 129,046 peaks for the alpha cells and 120,116
peaks for the beta cells using MACS2. However, because the delta
cluster had only 28 cells (corresponding tow2 M reads), we reasoned
that MACS2 would not perform ideally on data with such low depth.
Indeed, we identiﬁed only 49,293 peaks using MACS2 on the delta cell
aggregate reads.
3.3. Deep learning enables robust peak calls on less abundant
delta cells
To solve the challenge of learning cell-type-speciﬁc features from the
sparse signal in the low-count delta cell cluster, we developed a novel
a deep learning approach based on the U-Net architecture (Fig. S2A).
U-Net was ﬁrst developed for biomedical image segmentation but has
since been applied to many other problems including audio and super
resolution images. Its use in the super resolution problem served as
the main impetus for our choice of model to upscale genomic signals.
We formulated our approach as a classiﬁcation problem in which we
used sparse signal and corresponding peak calls to predict dense and
high-quality peak calls. To avoid overﬁtting and create a robust,
generalizable model, we adopted a rigorous training scheme. We
divided the chromosomes into training, validation, and testing sets
(Figure 3A, Figure S2B) and tested the performance of the models
within the same cell type as well as across different cell types. We
reasoned that our islet sci-ATAC-seq data were an ideal ﬁt for this
problem as all of the nuclei came from the same individual and pro-
cessing batch and should, therefore, contain no genetic or technical
biases that would inﬂuence within or across cell-type predictions.
Because we had high-quality data from two cell types, we trained two
models: one model was trained using 28-cell and 600-cell data from
the alpha cells (alpha-trained model), while the second model was
trained similarly on the data from the beta cells (beta-trained model).
We then compared peak predictions from both models to corre-
sponding MACS2 peaks from the 600-cell data. We found that theMOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier GmbH. This is an open access artic
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the MACS2 peak results as measured by the mean average precision
(Figure 3B), suggesting that the U-Net model was able to reconstruct
peak calls from sparse signals independent of the speciﬁc cell type it
was trained on. We highlight several examples in which the model was
able to successfully predict peaks that were absent in the sparse 28-
cell data but present in the 600-cell data of a cell type (Figure 3C).
Because the training cell type had no signal or peak at the given locus,
these predictions could not have been transferred or “copied over”
from the training data, indicating a possible use across cell types or
tissues. Based on these results, we used the U-Net models to predict
peaks for the low-count delta cell cluster. As the U-Net model provides
a posterior probability score for each peak call prediction, we sought to
create a high-conﬁdence set of predicted peak calls for each cell type.
We used a threshold of 0.625 to ﬁlter the predicted peaks for each cell
type. The choice of threshold was used to control for potential false
positives and the ﬁnal number of predicted cell-type peaks
(Figs. S2CeD). Further, considering that the delta peak predictions
from both the alpha and beta models were highly concordant (Jaccard
index of 0.85), we used the intersection of the results as the ﬁnal
predicted outcome. We then validated our peak predictions using an
orthogonal strategy in which we computed the enrichment of scRNA-
seq derived signature genes (scRSGs) for the alpha, beta, and delta
cells across chromatin accessibility peaks. We found that the scRSGs
for each cell type consistently had higher enrichment in the predicted
peaks than the MACS2 peaks derived from the same 28-cell data
(Figure 3D), indicating that our predicted peaks captured cell-type
speciﬁcity. In the next step, we compared them to the bulk islet
ATAC-seq master peak calls (Table S5). We found that master peaks
derived from the bulk islets were highly reproducible across samples,
with >70% of the peaks occurring in ﬁve or more of the 10 samples
(Figure 3E). Predictably, we also observed that the chromatin states
corresponding to “active TSS” and “active enhancer” showed
enrichment with increasing reproducibility of the master peaks. Like-
wise, chromatin states such as “repressed polycomb,” “weak tran-
scription,” and “quiescent/low signal” showed a depletion with the
increasing islet ATAC-seq peak reproducibility (Figure 3F). Similarly,
when we compared the cell-type peaks to the master peaks, we found
that the proportion of peaks from each cell type increased with the
increasing reproducibility of the bulk peaks (Figure 3G), suggesting
that highly reproducible peaks were driven by all of the constituent cell
types while the peaks that occurred in fewer samples might have
originated from underlying cell-population variability. For further vali-
dation, we also compared our cell-type peaks and sorted cell-type
population peaks [19,20] with master peaks derived from 33 inde-
pendent bulk islet ATAC-seq samples (Table S8) and observed a high
degree of concordance (Fig. S2E). For example, >90% of the alpha
and beta peaks were reproducible across three or more ATAC-seq
samples, which was comparable to the 85e92% peak overlap
observed for alpha and beta cell-type peaks from sorted cell pop-
ulations in previous studies [19,20]. While the primary model of our
interest was trained using data from 28 cells to predict 600-cell
equivalent peaks, we asked if the model would perform similarly for
a varying resolution of input data. To accomplish this, we subsampled
cells from alpha and beta cell clusters to sets of different cell counts,
starting with as few as ﬁve cells to 500 cells. We found that the
performance of the model increased with the increasing number of
cells used in the input training data (Fig. S2F). There was up to a ﬁve-
fold gain in the coverage of the T2D GWAS SNPs in the beta predicted
peaks compared to the MACS2 peaks (Fig. S2G) even when fewer cellsle under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 115
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Figure 3: Deep learning upscaling from sparse low-count nuclei clusters. (A) Schematic of the U-Net training scheme. Two models are depicted in the illustration: one trained
on alpha cells data as input and other trained on beta cells as input. Delta cell peak predictions from both models are combined to obtain ﬁnal predictions (see Methods). (B)
Precision-recall curve comparing peak calls from MACS2 on downscaled data (alpha cell type) with predicted peak calls from the 28-cell U-Net model (trained on beta, predicted on
alpha). (C) Example loci illustrating peak upscaling with the model. For each cell type, four tracks are shown: full signal track, peak calls on full data, peak calls on subsampled
data, and predicted peak calls. The predicted peak calls are obtained from a model trained on a different cell type. For delta predicted peak calls, intersection of prediction from
both alpha and beta models are shown. Signal tracks normalized to one million reads and scaled between 0 and 2. (D) Fold enrichment (log2) of single-cell RNA-seq derived
signature genes (scRSGs) in 28-cell MACS2 and U-Net predicted peaks for three cell types. (E) Reproducibility of master peaks from bulk islet ATAC-seq across individual samples.
(F) Fold enrichment (log2) of different sets of reproducible peaks from bulk islet ATAC-seq across 13 islet chromatin states. Genic enhancer is not shown because of no enrichment.
(G) Overlap of cell-type peaks (alpha, beta, and predicted delta) with different sets of reproducible peaks from bulk islet ATAC-seq data.
Original Articlewere used as input training data (Fig. S2H). These results suggest that
the deep learning strategy is applicable to a range of input data
typically seen in single-cell sequencing experiments.
Overall, our results show that deep learning driven feature prediction
can help recover tissue and cell-type relevant chromatin accessibility
patterns from sparse and noisy data. Using this approach can enhance
biological discoveries, which is challenging with rare cell populations.
3.4. T2D GWAS enrichment at cell-type-speciﬁc chromatin
signatures
We computed the overlap enrichment of T2D GWAS loci in cell-type
peak annotations from the alpha, beta, and delta cells using a
Bayesian hierarchical model as implemented in fGWAS [46]. fGWAS
allows calculation of marginal enrichment associations for one cell type
conditioned on another using not only the subset of genome-wide
signiﬁcant loci but also the full genome-wide association summary
statistics. We observed that annotations from all three cell types were
highly enriched for T2D GWAS loci, with beta-cell annotations having
the highest enrichment values (Figure 4A). However, when we
accounted for marginal associations using a joint model, we found that
the beta cells were the only cell type to remain enriched after adjusting
for the other two cell types. This result suggests that shared or beta
cell-speciﬁc chromatin accessibility peaks drive the association with
T2D GWAS. More broadly, these ﬁndings illustrate how single-cell
chromatin proﬁling results, when coupled with conditional statistical
enrichment analyses, can dissect speciﬁc cell types that drive
enrichment in bulk tissue samples.116 MOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier G
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types shared by each peak. Because the delta cell cluster had fewer
reads compared to the alpha and beta cells, we did not utilize read-
count-based approaches to determine cell-type-speciﬁc peaks.
Instead, we used peak level metrics to identify peaks exclusive to a
combination of cell types. We found that a majority of the peaks
(47,209) were shared across all cell types and that each cell type
had a set of unique accessible sites (29,884 beta, 39,353 alpha,
and 31,330 delta) (Figure 4B). Consistent with our expectations,
TSS-proximal shared peaks mostly overlapped active TSS chromatin
states compared to cell-type-speciﬁc peaks that had a larger pro-
portion of peaks in active enhancer states (Fig. S3A). To further
understand the regulatory logic, we looked for TF motifs enriched in
cell-type-speciﬁc peaks using GAT [30]. We found enrichment of
motifs implicated in islet cell-type-speciﬁc functionality consistent
with known islet TFs (Fig. S3B). For example, PDX1 was enriched in
beta-speciﬁc peaks, while GATA6 and FOXA were enriched in alpha-
speciﬁc peaks. We also observed enrichment of motifs relevant to
endocrine function such as PAX6 and MAF. For delta cell peaks,
HHEX was the only TF signature gene (out of 17 scRNA-seq cell-
type signature genes) that encoded a transcription factor, but we
observed no delta-speciﬁc enrichment. We think this could be
because HHEX is a member of the homeobox family of TFs and
therefore has a highly degenerate motif, which could result in less
speciﬁc enrichment within delta-speciﬁc peaks. Overall, the alpha
and beta peak motif enrichments were consistent with known cell-
speciﬁc TFs. We then used a complementary enrichment approachmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 4: Enrichment of T2D GWAS signals in cell-type-speciﬁc chromatin and linking them to target genes. (A) Fold enrichment (log2) of T2D GWAS SNPs in cell-type
peaks in single and conditional analysis mode using the fGWAS tool. For each cell type, three enrichment values with 95% conﬁdence intervals are shown: none (single-annotation
mode), alpha (conditioned on alpha), beta (conditioned on beta), and delta (conditioned on delta). (B) Partitioning of alpha, beta, and predicted delta peaks in mutually exclusive sets
of cell-type-speciﬁc peaks. The subplot (on right) shows the total number of peaks for each cell type. (C) Distance-matched Fisher odds that beta cell co-accessibility links overlap
islet Hi-C, islet pcHi-C, and ChIA-PET chromatin loops across different co-accessibility threshold bins. (D) Overlap of T2D GWAS credible set SNPs with cell-type-speciﬁc peaks. Bin
is colored if there is at least one SNP (PPAg > 0.05) in the 99% genetic credible set of the T2D GWAS signal located within 1 kb of an ATAC-seq peak. The Cicero score columns
are colored to indicate the score of the highest scoring link to the target gene. (E) Viewpoint plot of alpha Cicero connections centered at rs7163757 for C2CD4A/B locus. (F) Alpha
Cicero connections centered at rs11708067 for ADCY5 locus. (G) Beta Cicero connections centered at rs13262861 for ANK1 locus. (H) Cicero connections for both alpha and beta
centered at rs62059712 for ATP1B2 locus. The viewpoint region spans 1 kb from the variant.with the GREGOR tool [45] to determine if T2D GWAS loci were
enriched in each subclass of peaks. We found that the T2D GWAS
loci were highly enriched in shared peaks (p-value ¼ 1.64e-16, fold
enrichment ¼ 2.03) and beta cell-speciﬁc peaks (p-value ¼ 6.42e-
6, fold enrichment ¼ 1.91) (Fig. S3C). We also observed moderate
enrichment of T2D GWAS SNPs in other sets of cell-type-speciﬁc
peaks, but strikingly, there was little enrichment in delta cell-
speciﬁc peaks (p-value ¼ 3.12e-3, fold enrichment ¼ 1.55) and
no signiﬁcant enrichment in alpha cell-speciﬁc peaks (p-
value ¼ 1.83e-01, fold enrichment ¼ 1.16). This suggests that the
role of alpha and delta cells in the mechanisms underlying genetic
predisposition to T2D pathophysiology might be limited compared to
beta cells. To further elucidate the role of shared peaks in islet
endocrine-speciﬁc peaks and constitutive peaks shared across
more broad cell types, we added peaks from a sorted acinar cell
population. We observed that acinar-speciﬁc peaks showed no
enrichment (p-value ¼ 0.31, fold enrichment ¼ 1.10) (Fig. S3D).
These independent enrichment ﬁndings from the GREGOR tool wereMOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier GmbH. This is an open access artic
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indicating the robust nature of these results.
3.5. Linking cell-type-speciﬁc chromatin accessibility to target
genes
One of the primary challenges in understanding the underlying biological
mechanisms of non-coding T2D GWAS variants is the identiﬁcation of
their target genes. Risk variants occurring in enhancer regions can often
interact with their target genes that are not adjacent. Multiple studies
have examined the regulatory landscape of pancreatic islets and rele-
vant cell lines using chromosome conformation capture techniques to
nominate target genes [51e53]. However, most of these studies were
conducted on bulk islet samples, thereby obscuring any cell-speciﬁc
signatures of chromatin looping. Additionally, chromatin looping
studies tend to have noisy signals when two regions are close in linear
space, which leads to a bias toward detecting longererange in-
teractions. To mitigate these limitations, we adopted a recently pub-
lished approach, Cicero [50], which leverages proﬁles of chromatin co-le under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 117
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Original Articleaccessibility across single cells to infer pairs of chromatin peaks that are
likely to be in close physical proximity. For this analysis, we focused on
alpha and beta cell types as they were the clusters with the most nuclei.
To ﬁlter the Cicero co-accessibility scores for the peak pairs that are
more likely to represent true looping, we compared our results to
experimentally deﬁned loops from three orthogonal and independent
chromatin looping datasets: islet Hi-C [51], islet promoter capture Hi-C
(pcHi-C) [52], and EndoC Pol2 ChIA-PET [53] loops. We found that Cicero
peak pairs from our sci-ATAC-seq data with scores>0.05were strongly
enriched to be considered loops in each of the three reference data sets
(Figure 4C and Figure S4A). Using this threshold, we found 190,176 beta
cell and 147,716 alpha cell co-accessible peak pairs.
Using our new catalog of Cicero-inferred chromatin loops, we next
sought to link TSS-distal T2D GWAS variants to target gene promoters.
We focused on the latest T2D GWAS results and used SNPs in asso-
ciation signals that were genetically ﬁne-mapped to be in a 99%
credible set and had a >0.05 posterior probability of association
(PPAg) [3]. For this mapping procedure, we required that the credible
set SNP was not within 1 kb of an annotated TSS and that the other end
of the chromatin loop occurred within 1 kb of an annotated TSS. Using
this approach across both alpha and beta cells, we found that of the
265 independent GWAS signals containing SNPs that met our criteria,
we were able to nominate target genes at 104 of them (Figure 4D). In a
similar manner, we checked if the SNPs within each locus overlapped
a cell-type-speciﬁc peak (Table S6). We observed several notable
examples. At the C2CD4A/B locus, we found rs7163757 (PPAg 0.095)
to be linked to C2CD4B in the alpha cells (Figure 4E). Using an islet
gene expression and genetic integration approach to identify expres-
sion quantitative trait loci (eQTL), we previously showed that
rs7163757 is associated with C2CD4B expression [8], and a subse-
quent functional study corroborated these ﬁndings [58]. At a different
locus, we found rs11708067 (PPAg 0.79) located in an islet enhancer
within the ADCY5 gene to be linked to the TSS of the corresponding
gene (Figure 4F). The risk allele of rs11708067 has been reported to
be associated with reduced expression of ADCY5 [59], and functional
validation experiments show an association with impaired insulin
secretion [4,9]. As an example of a beta cell-speciﬁc connection, we
found variant rs13262861 (PPAg 0.97) within the ANK1 locus to be
linked to nearby NKX6-3 (Figure 4G). We previously used islet eQTL
data to nominate NKX6-3 as an islet target gene at this locus [4,8]. The
extensive support from previous publications for these three loci serves
as positive controls for our results and reinforces the quality of this sci-
ATAC-seq data and analyses. Finally, we highlight rs62059712 (PPAg
0.34) within the ATP1B2 locus as an example of a variant linked to
multiple gene promoters across both beta and alpha cell types
(Figure 4H). Notably, of the 104 T2D GWAS signals for which we were
able to nominate target genes in either cell type, 60 (w58%) had more
than one nominated target gene.
4. DISCUSSION
Single-nuclei chromatin accessibility proﬁling provides a unique
approach for mapping cell-type-speciﬁc regulatory signatures. In this
study, we utilized the sci-ATAC-seq protocol to generate and study
chromatin accessibility proﬁles for 1,456 high-quality nuclei from a
puriﬁed pancreatic islet sample. Our dataset and analyses provide
high-quality maps of cell-type accessibility proﬁles and regulatory
architecture using an unbiased approach compared to prior maps from
sorted cell-type populations. Our validation analyses span data from
seven independent publications and encompass different aspects of
our experiments and computational analyses and uniformly support the118 MOLECULAR METABOLISM 32 (2020) 109e121 Published by Elsevier G
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emphasize that single-cell data present unique challenges, and that
our study, which analyzed only one pancreatic islet sample, may be
limited in how it can address some problems.
First, de novo identiﬁcation of cell types and within-cluster heteroge-
neity from sparse single-cell chromatin accessibility data continues to
be a challenge. We adopted several strategies to address potential
biases in our analyses. Our logistic regression approach to eliminate
read depth as a confounding technical variable, combined with the
binomial counting strategy to infer doublet enrichment in clusters,
enabled us to identify three major cell-type populations corresponding
to alpha, beta, and delta cells. To assign these cell identities, we relied
not only on classical hormone markers but also leveraged ﬁndings
from independent islet single-cell RNA-seq studies to validate our
results. While islets have been reported to contain other rarer cell-type
populations (<5% of all islet cells) [56], our ability to observe them
was limited due to the size of our dataset. We were also limited in our
ability to analyze within-cluster heterogeneity due to relatively low
number of cells in each cluster (for instance, only 701 beta cells) and
the availability of only one sample.
Second, we faced the challenge of identifying reliable cell-speciﬁc
accessibility patterns across all cell types due to the relatively low
abundance of delta cells. As such, our U-Net-based deep learning
approach presents a novel strategy for addressing this particular
problem. Our model differs from a related deep learning method, Coda
[60], by focusing on single-cell ATAC-seq as opposed to bulk histone
ChIP-seq data and uses a more complex architecture (U-Net) that has
been previously used in image processing related tasks [40,61] but
has been seldom used in genomics [62]. Using alpha and beta cells as
reciprocal training and testing datasets, we demonstrated that our
model successfully learns to predict high-quality peak calls from low
cell count data. We validate our upscaled peaks using orthogonal data
from independent scRNA-seq study and show that upscaled peaks
have higher enrichment of cell-type signature genes compared to
MACS2 peaks. However, there are diminishing returns from using deep
learning models when 200 or more cells are used as input to the
model, an observation consistent with the threshold of experimental
reproducibility highlighted in a recent large-scale single-nuclei ATAC-
seq study [15]. This consistency with an independent study reinforces
the value of our deep learning approach but also highlights a limitation
of our delta peak predictions that derive from a low cell count input
dataset. Our observation also provides a strategy for experimental
design in which a certain number of samples might be desirable to
ensure a minimum performance. We envision that our method will be
useful under scenarios in which it is challenging or cost-prohibitive to
obtain speciﬁc cell populations.
Overall, an important implication of our ﬁndings comes from our ability
to generate cell-speciﬁc chromatin accessibility maps and infer looping
connections from accessible regions to target genes of T2D GWAS
variants. A recent T2D GWAS [3] reported > 400 independent asso-
ciation signals, but the molecular mechanisms underlying these sig-
nals was known only for a subset of the variants. Single-nuclei
resolution cell-speciﬁc regulatory signatures provide a unique oppor-
tunity to infer target gene links with non-coding elements. Thus, we
integrated cell-type co-accessibility links with T2D GWAS SNPs that
were genetically ﬁne-mapped to 99% credible sets to create a higher-
resolution map of the regulatory landscape underlying 104 distinct T2D
GWAS signals. Focusing on the cell speciﬁcity of the chromatin
accessibility peaks that anchor these target gene associations, we
observed seven classes, representing: i) peaks that were unique to a
cell type (three classes), ii) peaks that were shared across all three cellmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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types (one class), and iii) peaks that occurred in a pair of cell types
(three classes). Interestingly, the class of peaks shared across all three
cell types comprised 26 of the 104 (25%) T2D GWAS to target gene
links even though this class was only one of seven. These results paint
a complex picture of disease mechanisms in which certain risk vari-
ants may mediate target effects through cell-type-speciﬁc pathways,
while others might affect multiple target genes shared across cell-type
populations.
We noted speciﬁc examples at the C2CD4A/B and ANK1 loci in which
we were able to nominate speciﬁc variants linked with islet gene
expression and their role in T2D pathophysiology as compelling targets
for future mechanistic studies. At the time of writing this manuscript,
another similar study appeared as a preprint [63], and as such, an
important future topic will be to combine and meta-analyze multiple
islet single-cell ATAC-seq datasets. Such an endeavor will increase
statistical power to detect chromatin features, including loops, at
GWAS loci, and eventually enable single-cell resolution chromatin QTL
studies, which will help to further focus on functional SNPs. Overall, we
believe that the data, results, and methodology from this study will be
of value to the broader research community.
5. DATA AVAILABILITY
The data reported in this paper were deposited in the database of
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at https://github.com/ParkerLab/islet_sci-ATAC-seq_2019. Additional
URLs are provided in Table S7 of the Supplementary Data.
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